Category Archives: News

IDIBELL and Pharmacelera sign a research agreement to find new drugs with anticancer applications

Researchers at Bellvitge Biomedical Research Institute will develop a research project with the company Pharmacelera to look for new molecules that block the cohesin complex, with applications in several difficult-to-treat cancers, such as myeloid leukemia, glioblastomas, Ewing sarcomas, colon cancer and bladder cancer. The cell cycle research group of the Bellvitge Biomedical Research Institute (IDIBELL),…
Read more

Bosch i Gimpera Foundation Award

Professor Javier Luque (h-index of 66), Pharmacelera’s Scientific Director, has received the 10th edition award from the Boschi Gimpera Foundation for his technology transfer efforts from the University of Barcelona to Pharmacelera. Professor Luque has supervised the use of molecular models based on Quantum-Mechanics (QM) computations derived from more than 20 years of research for…
Read more